140 related articles for article (PubMed ID: 35729536)
1. Neuroendocrine pathways and breast cancer progression: a pooled analysis of somatic mutations and gene expression from two large breast cancer cohorts.
Hu K; Wang C; Luo C; Zheng H; Song H; Bergstedt J; Fall K; Luo T; Czene K; Valdimarsdóttir UA; Fang F; Lu D
BMC Cancer; 2022 Jun; 22(1):680. PubMed ID: 35729536
[TBL] [Abstract][Full Text] [Related]
2. Mammography radiomics features at diagnosis and progression-free survival among patients with breast cancer.
Luo C; Zhao S; Peng C; Wang C; Hu K; Zhong X; Luo T; Huang J; Lu D
Br J Cancer; 2022 Nov; 127(10):1886-1892. PubMed ID: 36050449
[TBL] [Abstract][Full Text] [Related]
3. The transcription factor CBFB mutations indicate an improved survival in HR+/HER2- breast cancer.
Guo L; Chen B; Zhang G; Wang Y; Cao L; Ren C; Wen L; Lin J; Wei G; Liao N
Gene; 2020 Oct; 759():144970. PubMed ID: 32711101
[TBL] [Abstract][Full Text] [Related]
4. Toward the precision breast cancer survival prediction utilizing combined whole genome-wide expression and somatic mutation analysis.
Zhang Y; Yang W; Li D; Yang JY; Guan R; Yang MQ
BMC Med Genomics; 2018 Nov; 11(Suppl 5):104. PubMed ID: 30454048
[TBL] [Abstract][Full Text] [Related]
5. Targeted next-generation sequencing identifies clinically relevant somatic mutations in a large cohort of inflammatory breast cancer.
Liang X; Vacher S; Boulai A; Bernard V; Baulande S; Bohec M; Bièche I; Lerebours F; Callens C
Breast Cancer Res; 2018 Aug; 20(1):88. PubMed ID: 30086764
[TBL] [Abstract][Full Text] [Related]
6. GATA3 mutations define a unique subtype of luminal-like breast cancer with improved survival.
Jiang YZ; Yu KD; Zuo WJ; Peng WT; Shao ZM
Cancer; 2014 May; 120(9):1329-37. PubMed ID: 24477928
[TBL] [Abstract][Full Text] [Related]
7. Integration of somatic mutation, expression and functional data reveals potential driver genes predictive of breast cancer survival.
Suo C; Hrydziuszko O; Lee D; Pramana S; Saputra D; Joshi H; Calza S; Pawitan Y
Bioinformatics; 2015 Aug; 31(16):2607-13. PubMed ID: 25810432
[TBL] [Abstract][Full Text] [Related]
8. GATA3 somatic mutations are associated with clinicopathological features and expression profile in TCGA breast cancer patients.
Afzaljavan F; Sadr AS; Savas S; Pasdar A
Sci Rep; 2021 Jan; 11(1):1679. PubMed ID: 33462316
[TBL] [Abstract][Full Text] [Related]
9. PEG3 mutation is associated with elevated tumor mutation burden and poor prognosis in breast cancer.
Zhang M; Zhang J
Biosci Rep; 2020 Aug; 40(8):. PubMed ID: 32729618
[TBL] [Abstract][Full Text] [Related]
10. The genetic landscape of breast carcinomas with neuroendocrine differentiation.
Marchiò C; Geyer FC; Ng CK; Piscuoglio S; De Filippo MR; Cupo M; Schultheis AM; Lim RS; Burke KA; Guerini-Rocco E; Papotti M; Norton L; Sapino A; Weigelt B; Reis-Filho JS
J Pathol; 2017 Feb; 241(3):405-419. PubMed ID: 27925203
[TBL] [Abstract][Full Text] [Related]
11. Biological and clinical features of triple negative Invasive Lobular Carcinomas of the breast. Clinical outcome and actionable molecular alterations.
Conforti F; Pala L; Pagan E; Rocco EG; Bagnardi V; Montagna E; Peruzzotti G; De Pas T; Fumagalli C; Pileggi S; Pesenti C; Marchini S; Corso G; Marchio' C; Sapino A; Graffeo R; Collet L; Aftimos P; Sotiriou C; Piccart M; Gelber RD; Viale G; Colleoni M; Goldhirsch A
Breast; 2021 Oct; 59():94-101. PubMed ID: 34217971
[TBL] [Abstract][Full Text] [Related]
12. Comprehensive Analysis of Metabolic Genes in Breast Cancer Based on Multi-Omics Data.
Hua Y; Gao L; Li X
Pathol Oncol Res; 2021; 27():1609789. PubMed ID: 34408553
[No Abstract] [Full Text] [Related]
13. Association of MUC16 Mutation With Tumor Mutation Load and Outcomes in Patients With Gastric Cancer.
Li X; Pasche B; Zhang W; Chen K
JAMA Oncol; 2018 Dec; 4(12):1691-1698. PubMed ID: 30098163
[TBL] [Abstract][Full Text] [Related]
14. Somatic mutation load of estrogen receptor-positive breast tumors predicts overall survival: an analysis of genome sequence data.
Haricharan S; Bainbridge MN; Scheet P; Brown PH
Breast Cancer Res Treat; 2014 Jul; 146(1):211-20. PubMed ID: 24839032
[TBL] [Abstract][Full Text] [Related]
15. An integrative bioinformatics approach reveals coding and non-coding gene variants associated with gene expression profiles and outcome in breast cancer molecular subtypes.
Győrffy B; Pongor L; Bottai G; Li X; Budczies J; Szabó A; Hatzis C; Pusztai L; Santarpia L
Br J Cancer; 2018 Apr; 118(8):1107-1114. PubMed ID: 29559730
[TBL] [Abstract][Full Text] [Related]
16. High expression of the vacuole membrane protein 1 (VMP1) is a potential marker of poor prognosis in HER2 positive breast cancer.
Amirfallah A; Arason A; Einarsson H; Gudmundsdottir ET; Freysteinsdottir ES; Olafsdottir KA; Johannsson OT; Agnarsson BA; Barkardottir RB; Reynisdottir I
PLoS One; 2019; 14(8):e0221413. PubMed ID: 31442252
[TBL] [Abstract][Full Text] [Related]
17. Contralateral parenchymal enhancement on MRI is associated with tumor proteasome pathway gene expression and overall survival of early ER+/HER2-breast cancer patients.
Ragusi MAA; Bismeijer T; van der Velden BHM; Loo CE; Canisius S; Wesseling J; Wessels LFA; Elias SG; Gilhuijs KGA
Breast; 2021 Dec; 60():230-237. PubMed ID: 34763270
[TBL] [Abstract][Full Text] [Related]
18. Genomic and Expression Analyses Define MUC17 and PCNX1 as Predictors of Chemotherapy Response in Breast Cancer.
Al Amri WS; Allinson LM; Baxter DE; Bell SM; Hanby AM; Jones SJ; Shaaban AM; Stead LF; Verghese ET; Hughes TA
Mol Cancer Ther; 2020 Mar; 19(3):945-955. PubMed ID: 31879365
[TBL] [Abstract][Full Text] [Related]
19. Exomes of Ductal Luminal Breast Cancer Patients from Southwest Colombia: Gene Mutational Profile and Related Expression Alterations.
Cortes-Urrea C; Bueno-Gutiérrez F; Solarte M; Guevara-Burbano M; Tobar-Tosse F; Vélez-Varela PE; Bonilla JC; Barreto G; Velasco-Medina J; Moreno PA; Rivas JL
Biomolecules; 2020 Apr; 10(5):. PubMed ID: 32365829
[TBL] [Abstract][Full Text] [Related]
20. Immune gene expression profiling reveals heterogeneity in luminal breast tumors.
Zhu B; Tse LA; Wang D; Koka H; Zhang T; Abubakar M; Lee P; Wang F; Wu C; Tsang KH; Chan WC; Law SH; Li M; Li W; Wu S; Liu Z; Huang B; Zhang H; Tang E; Kan Z; Lee S; Park YH; Nam SJ; Wang M; Sun X; Jones K; Zhu B; Hutchinson A; Hicks B; Prokunina-Olsson L; Shi J; Garcia-Closas M; Chanock S; Yang XR
Breast Cancer Res; 2019 Dec; 21(1):147. PubMed ID: 31856876
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
